Commentary on Post, et al. Ultra-early tranexamic acid after subarachnoid hemorrhage: A randomized controlled trial. Lancet 2021

BACKGROUND: Tranexamic acid (TA) administration in aneurysmal subarachnoid hemorrhage (SAH) within the first 24 hours may reduce the incidence of early aneurysmal rebleeding. However, this is also the potential for an increased risk of delayed cerebral ischemia if TA is administered for more than 72...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Surg Neurol Int
Main Authors: Lo, Benjamin W. Y., Fukuda, Hitoshi, Tsang, Anderson C. O., Langer, David J., Miyawaki, Satoru, Koyanagi, Masaomi, Lui, Matthew Wai-Man
Formato: Artigo
Idioma:Inglês
Publicado em: Scientific Scholar 2021
Assuntos:
Commentary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088487/
https://ncbi.nlm.nih.gov/pubmed/33948326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.25259/SNI_242_2021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados